Phase 3 Randomized Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Phase of Trial: Phase III
Latest Information Update: 29 Sep 2017
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 21 Sep 2017 Planned End Date changed from 1 Jan 2018 to 1 May 2018.
- 11 May 2016 Status changed from not yet recruiting to recruiting.
- 03 Feb 2016 New trial record